Umbhali: Mark Sanchez
Umhla Wokudalwa: 27 Eyomqungu 2021
Hlaziya Umhla: 29 Eyomqungu 2025
Anonim
The Amazing Benefits of Berberine
Ividiyo: The Amazing Benefits of Berberine

Umxholo

IBerberine yikhemikhali efumaneka kwizityalo ezininzi kubandakanya i-barberry yaseYurophu, igolide, igolide, icelandine enkulu, iidiliya iOregon, iphellodendron, kunye neturmeric yomthi.

I-Berberine ixhaphakileyo ithathwa isifo seswekile, amanqanaba aphezulu e-cholesterol okanye amanye amafutha (lipids) egazini (hyperlipidemia), kunye noxinzelelo lwegazi. Isetyenziselwa ukutshisa, izilonda zomhlaza, isifo sesibindi, kunye nezinye iimeko ezininzi kodwa abukho ubungqina obuchanekileyo benzululwazi obuxhasa uninzi lwezi zinto zisetyenziswayo.

Amayeza endalo aVimba weDatha Ukusebenza kwexabiso ngokusekwe kubungqina besayensi ngokwala manqanaba alandelayo: Ukusebenza, ukusebenza ngokukuko, okunokwenzeka ukuba kusebenze, okungenzeka kungasebenzi, kunokwenzeka ukungasebenzi, ukungasebenzi, kunye nobungqina obungonelanga bokulinganisa.

Ukulinganiswa kokusebenza kwe Amagama amaninzi aqhelekileyo kunye aqhelekanga ngegama Berner zezi zilandelayo:

Inokwenzeka ukuba isebenze ...

  • Izilonda zenqanawa. Uphando lubonisa ukuba ukusebenzisa ijeli ene-berberine kunokunciphisa iintlungu, ukuba bomvu, ukuqaqamba, kunye nobungakanani bezilonda kubantu abanezilonda.
  • Seswekile. IBerberine ibonakala inciphisa kancinci amanqanaba eswekile yegazi kubantu abanesifo seswekile. Kwakhona, uphando lwakwangoko lubonisa ukuba ukuthatha i-500 mg ye-berberine amaxesha ama-2-3 yonke imihla ukuya kuthi ga kwiinyanga ezintathu kunokulawula iswekile yegazi ngokufanelekileyo njenge-metformin okanye i-rosiglitazone.
  • Amanqanaba aphezulu e-cholesterol okanye amanye amafutha (lipids) egazini (hyperlipidemia). I-Berberine inokunceda ukunciphisa amanqanaba e-cholesterol kubantu abane-cholesterol ephezulu. Ukuthatha iberberine ukuya kuthi ga kwiminyaka emibini kubonakala kunciphisa i-cholesterol iyonke, i-low-density lipoprotein (LDL okanye "embi") ye-cholesterol, kunye namanqanaba e-triglyceride kubantu abane-cholesterol ephezulu. Xa kuthelekiswa namayeza asezantsi e-cholesterol, i-berberine ibonakala ibangela utshintsho olufanayo kwi-cholesterol iyonke, i-cholesterol ye-LDL, kunye ne-lipoprotein ephezulu (HDL okanye "elungileyo") ye-cholesterol, kwaye kunokuba ngcono ekunciphiseni amanqanaba e-triglyceride.
  • Igazi elonyukayo. Ukuthatha i-0.9 gram ye-berberine ngosuku kunye noxinzelelo lwegazi-ukunciphisa amlodipine iziyobisi kunciphisa uxinzelelo lwegazi (inombolo ephezulu) kunye noxinzelelo lwegazi lwe-diastolic (inani elisezantsi) ngcono kunokuthatha i-amlodipine yodwa kubantu abanexinzelelo lwegazi.
  • Ingxaki yehomoni ebangela ukwandisa ii-ovari kunye nee-cysts (i-polycystic ovary syndrome okanye i-PCOS). Uphando lubonisa ukuba i-berberine inganciphisa iswekile yegazi, iphucule i-cholesterol kunye ne-triglyceride, ukunciphisa amanqanaba e-testosterone, kunye ne-low-to-hip ratio kwabasetyhini abane-PCOS. I-Berberine isenokunciphisa amanqanaba eswekile yegazi ngokufanayo kwi-metformin kwaye inokuphucula amanqanaba e-cholesterol ngcono kune-metformin. Akucaci ukuba i-berberine inyusa amazinga okukhulelwa okanye amaxabiso okuzalwa aphilayo kwabasetyhini abane-PCOS.

Akukho bungqina baneleyo bokulinganisa ukusebenza ...

  • Ukutsha. Uphando lwakwangoko lubonisa ukuba ukusebenzisa ioyile ene-berberine kunye ne-beta-sitosterol kunokunyanga amanqanaba okutsha okwesibini ngokufanelekileyo njengonyango oluqhelekileyo nge-silver sulfadiazine.
  • Usulelo lwamathumbu olubangela urhudo (ikholera). Olunye uphando lwakwangoko lubonisa ukuba ukuthatha i-berberine sulfate kunganciphisa urhudo ngesixa esincinci kubantu abanekholera. Nangona kunjalo, i-berberine ayibonakali iphucula iziphumo ze-tetracycline ye-antibiotic ekunyangeni isifo sohudo esihambelana nosulelo lwekholera.
  • Ukukhula okungenawo umhlaza emathunjini amakhulu kunye ne-rectum (i-colorectal adenoma). Uphando lwakwangoko lubonisa ukuba ukuthatha i-berberine kangangeminyaka emi-2 kubonakala kuthintela ukubuyela kwakhona kwe-adenomas ebalulekayo kubantu esele benyangiwe koku kukhula.
  • Ukusilela kwentliziyo kunye nolwelo olwakha emzimbeni (ukungaphumeleli kwentliziyo okanye i-CHF). Uphando lwakwangoko lubonisa ukuba iberberine inokunciphisa ezinye zeempawu kwaye yehlise izinga lokufa kwabanye abantu abanesifo sentliziyo esisininzi.
  • Isifo sentliziyo. Uphando lubonisa ukuba ukuthatha imveliso ethile ene-berberine kunye nezinye izithako kwiinyanga ezintathu kunciphisa amanqanaba e-cholesterol kubantu abanesifo sentliziyo ababenenkqubo ebizwa ngokuba yi-percutaneous ungenelelo (PCI). Le mveliso ibonakala inciphisa amanqanaba e-cholesterol ngaphezu kweyeza eliqhelekileyo ezetimibe, esetyenziselwa ukunciphisa i-cholesterol. Ukuthatha le mveliso ngokudibeneyo kunye namayeza asezantsi amayeza abizwa ngokuba yi "statins" kubonakala kusebenza ngcono kunokuthatha ii-statins zedosi ephantsi zodwa. Akucaci ukuba iziphumo zale mveliso zibangelwa yi-berberine, ezinye izinto, okanye indibaniselwano. Akukaziwa nokuba le mveliso inciphisa umngcipheko weziganeko ezinxulumene nentliziyo kubantu abanesifo sentliziyo.
  • Urhudo. Olunye uphando lwakwangoko lubonisa ukuba ukuthatha i-berberine sulphate kunganciphisa urhudo kubantu abane-E. Coli usulelo.
  • Iqela lokuphazamiseka kwamehlo elinokukhokelela ekuphulukaneni nombono (glaucoma). Uphando lwakwangoko lubonisa ukuba ukusebenzisa amathontsi wamehlo ane-berberine kunye ne-tetrahydrozoline akulinciphisi uxinzelelo lwamehlo kubantu abane-glaucoma ngcono kunamathontsi wamehlo ane-tetrahydrozoline yodwa.
  • Usulelo lokugaya olunokukhokelela kwizilonda (Helicobacter pylori okanye H. pylori). Uphando lwakwangoko lubonisa ukuba ukuthatha iberberine kusebenza ngakumbi kune-ranitidine kunyango lwe-p. Pylori. Kodwa i-berberine ibonakala ingasebenzi kakuhle ekuphiliseni izilonda kubantu abanezilonda zesisu ngenxa kaH. Pylori. Olunye uphando lubonisa ukuba i-berberine inokunyanga usulelo lwe-p. Pylori kunye nonyango lwe-bismuth xa luthathwe ngokudibanisa nerejimeni esemgangathweni yamachiza amathathu osulelo luka-p. Pylori.
  • Ukudumba (ukudumba) kwesibindi okubangelwa yintsholongwane ye-hepatitis B (hepatitis B). Uphando lwakwangoko lubonisa ukuba iberberine inciphisa iswekile yegazi, amafutha egazi abizwa ngokuba yi-triglycerides, kunye neempawu zomonakalo wesibindi kubantu abanesifo seswekile kunye ne-hepatitis B.
  • Ukudumba (ukudumba) kwesibindi okubangelwa yintsholongwane ye-hepatitis C (hepatitis C). Uphando lwakwangoko lubonisa ukuba iberberine inciphisa iswekile yegazi, amafutha egazi abizwa ngokuba yi-triglycerides, kunye neempawu zomonakalo wesibindi kubantu abanesifo seswekile kunye ne-hepatitis C.
  • Ingxaki yexesha elide yamathumbu amakhulu ebangela iintlungu zesisu (isifo esiswini esinokucaphuka okanye i-IBS). Uphando lwakwangoko lubonisa ukuthatha i-berberine kabini yonke imihla kwiiveki ezisibhozo kunokunciphisa isifo sohudo kunye nentlungu yesisu kwaye kunokuphucula umgangatho wobomi kubantu abane-IBS abanesifo sorhudo.
  • Iimpawu zokuyeka ukuya exesheni. Uphando lwakwangoko lubonisa ukuba ukuthatha indibaniselwano ye-berberine kunye ne-soy isoflavones kunokunciphisa iimpawu ze-menopausal. Nangona kunjalo, akucaci ukuba i-berberine iyanciphisa iimpawu ze-menopausal ukuba isetyenziswe yodwa.
  • Ukuhlelwa kweempawu ezonyusa umngcipheko wesifo seswekile, isifo sentliziyo, kunye nokubetha (isifo se-metabolic syndrome). Uphando lwakwangoko lubonisa ukuba iberberine inciphisa ubunzima bomzimba (i-BMI), uxinzelelo lwegazi lwe-systolic (inani eliphezulu), amafutha egazi abizwa ngokuba yi-triglycerides, kunye namanqanaba eswekile yegazi kubantu abane-metabolic syndrome. Kukwabonakala ngathi kuphucula uvakalelo lwe-insulin. Olunye uphando lwakwangoko lubonisa ukuba ukuthatha imveliso yokudibanisa equle i-berberine, i-policosanol, irayisi ebomvu, i-folic acid, i-coenzyme Q10, kunye ne-astaxanthin iphucula uxinzelelo lwegazi kunye nokuhamba kwegazi kubantu abane-metabolic syndrome.
  • Ukwakha amanqatha esibindini kubantu abasela kancinci okanye bangaseli tywala (isifo sesibindi esinamafutha okanye i-NAFLD). Uphando lwakwangoko lubonisa ukuba iberberine inciphisa amanqatha egazini kunye namanqaku okwenzakala kwesibindi kubantu abanesifo seswekile kunye ne-NAFLD. Olunye uphando lwakwangoko lubonisa ukuba i-berberine inokunciphisa amanqatha esibindini, amanqaku okulimala kwesibindi, kunye nobunzima kubantu abakule meko. IBerberine ibonakala isebenza malunga nonyango lwe-pioglitazone.
  • Ukutyeba kakhulu. Uphando lwakwangoko lubonisa ukuba ukuthatha iberberine kunokunciphisa ubunzima kubantu abatyebe kakhulu malunga neepawundi ezi-5.
  • Urhudo olubangelwa lonyango lwemitha. Olunye uphando lwakwangoko lubonisa ukuba ukuthatha iberberine ngexesha lonyango lwemitha kunokunciphisa ukonzakala kwamathumbu ukusuka kwimitha kwizigulana ezinyangelwa umhlaza.
  • Ukuqhekeka kwethishu okubangelwa lonyango lwemitha. Olunye uphando lwakwangoko lubonisa ukuba ukuthatha iberberine ngexesha lonyango lwemitha kunokunciphisa ukwenzakala kwemiphunga kwimitha kwizigulana ezinyangelwa umhlaza.
  • Amanqanaba asezantsi eeplatelets egazini (thrombocytopenia). Iiplatelets zegazi zibalulekile ekunqandeni igazi. Uphando lwakwangoko lubonisa ukuba ukuthatha iberberine nokuba kukodwa okanye nge-prednisolone, kunokunyusa inani leeplatelets zegazi kubantu abaneeplatelet zegazi ezisezantsi.
  • Usulelo lwamehlo olubangelwa yiClamydia trachomatis (trachoma). Kukho ubungqina bokuba amathontsi wamehlo ane-berberine anokuba luncedo kunyango lwe-trachoma, unobangela oqhelekileyo wobumfama kumazwe asaphuhlayo.
  • Uhlobo lwesifo sokukrala kwamathumbu (ulcerative colitis). Uphando lwakwangoko lubonisa ukuba ukuthatha iberberine akubonakali kuphucula iimpawu kubantu abane-ulcerative colitis abathatha ichiza i-mesalamine.
  • Ezinye iimeko.
Ubungqina obungakumbi buyafuneka ukukala ukusebenza kwe-berberine kwezi zinto zisetyenziswayo.

IBerberine inokubangela ukubetha kwentliziyo ngamandla. Oku kunokunceda abantu abaneemeko ezithile zentliziyo. IBerberine inokunceda ekulawuleni indlela umzimba osebenzisa ngayo iswekile egazini. Oku kunokunceda abantu abanesifo seswekile. Kananjalo inokubanakho ukubulala iintsholongwane kunye nokunciphisa ukudumba.

Xa kuthathwa ngomlomo: IBerberine yiyo UKHUSELEKO OLUNOKWENZEKA uninzi lwabantu abadala basebenzise ixesha elifutshane. Iziphumo zibandakanya urhudo, ukuqhina, irhasi, isisu, kunye nentloko.

Xa isetyenziswa eluswini: IBerberine yiyo UKHUSELEKO OLUNOKWENZEKA kubantu abadala xa besebenzisa ixesha elifutshane.

Amanyathelo okhuseleko kunye nezilumkiso:

Ukukhulelwa kunye nokuncancisa: Nguwo NGOKUFANELEKILEYO ukuthatha iberberine ngomlomo ukuba ukhulelwe. Abaphandi bakholelwa ukuba i-berberine inokuwela i-placenta kwaye inokubangela ingozi kumntwana. I-Kernicterus, uhlobo lokonakala kwengqondo, ikhule kwiintsana ezisandul 'ukuzalwa ezichazwe kwi-berberine.

Kukwanjalo NGOKUFANELEKILEYO ukuthatha i-berberine ukuba uncelisa. IBerberine inokudluliselwa elusaneni ngobisi lwebele, kwaye inokubangela ingozi.

Abantwana: Nguwo NGOKUFANELEKILEYO ukunika iberberine kwiintsana ezisandul 'ukuzalwa. Ingabangela i-kernicterus, uhlobo olunqabileyo lomonakalo wengqondo olunokuthi lwenzeke kwiintsana ezisandul 'ukuzalwa ezine-jaundice enzima. I-jaundice ityheli kolusu okubangelwa yi-bilirubin eninzi egazini. IBilirubin yikhemikhali eveliswa xa iiseli ezindala ezibomvu ziwohloka. Ihlala isuswa sisibindi. I-Berberine inokugcina isibindi sisuse i-bilirubin ngokukhawuleza ngokwaneleyo. Akukho lwazi lwaneleyo lwanokuthenjwa lokwazi ukuba ngaba iberberine ikhuselekile kubantwana abadala.

Seswekile: IBerberine inokunciphisa iswekile yegazi. Ngokwethiyori, iberberine inokubangela ukuba iswekile esegazini ibe sezantsi kakhulu ukuba ithathwa ngabantu abaneswekile abalawula iswekile yegazi labo nge-insulin okanye amayeza. Sebenzisa ngononophelo kubantu abanesifo seswekile.

Amanqanaba aphezulu e-bilirubin egazini kwiintsana: I-Bilirubin yikhemikhali eveliswa xa iiseli ezindala ezibomvu zegazi zisonakala. Ihlala isuswa sisibindi. I-Berberine inokugcina isibindi sisuse i-bilirubin ngokukhawuleza ngokwaneleyo. Oku kunokubangela iingxaki zobuchopho, ngakumbi kwiintsana ezinamanqanaba aphezulu ebilirubin egazini. Kuphephe ukusebenzisa.

Uxinzelelo lwegazi oluphantsi: IBerberine inokuhlisa uxinzelelo lwegazi. Ngokwethiyori, iberberine inokunyusa umngcipheko woxinzelelo lwegazi ukuba lube sezantsi kakhulu kubantu esele benalo uxinzelelo lwegazi. Sebenzisa ngononophelo.

Mkhulu
Sukuyithatha le indibaniselwano.
ICyclosporine (iNeoral, iSandimmune)
Umzimba wophula i-cyclosporine ukuze uyilahle. IBerberine inganciphisa ukuba umzimba uphula kanjani ngokukhawuleza i-cyclosporine kwaye inokwakha emzimbeni kwaye inokubangela iziphumo ebezingalindelekanga.
Iphakathi
Lumka ngale nhlanganisela.
I-Dextromethorphan (iRobitussin DM, abanye)
Umzimba wophula i-dextromethorphan ukuze uyilahle. IBerberine inokunciphisa ngokukhawuleza ukuba umzimba uyaphula kwaye unokunyusa iziphumo kunye neziphumo ebezingalindelekanga ze-dextromethorphan.
ILosartan (iCozaar)
Isibindi senza ilosartan ukuba isebenze. IBerberine inokunciphisa ukuba umzimba uyisebenze ngokukhawuleza kangakanani na, kwaye unokunciphisa iziphumo zayo.
Amayeza atshintshwe sisibindi (iiCytochrome P450 2C9 (CYP2C9) substrates)
Amanye amayeza atshintshiwe kwaye aphulwe sisibindi. IBerberine inokunciphisa ngokukhawuleza ukuba isibindi siwaphula la mayeza kwaye sandise iziphumo kunye neziphumo ebezingalindelekanga.

Amanye amayeza atshintshwe sisibindi kubandakanya i-celecoxib (i-Celebrex), i-diclofenac (i-Voltaren), i-fluvastatin (i-Lescol), i-glipizide (i-Glucotrol), i-ibuprofen (i-Advil, i-Motrin), i-irbesartan (i-Avapro), i-losartan (i-Cozaar), i-phenytoin (i-Dilantin), i-piroxicam (Feldene), tamoxifen (Nolvadex), tolbutamide (Tolinase), torsemide (Demadex), kunye ne-S-warfarin (Coumadin).
Amayeza atshintshwe sisibindi (iiCytochrome P450 2D6 (CYP2D6) substrates)
Amanye amayeza atshintshiwe kwaye aphulwe sisibindi. IBerberine inokunciphisa ngokukhawuleza ukuba isibindi siwaphula la mayeza kwaye sandise iziphumo kunye neziphumo ebezingalindelekanga. Amanye amayeza atshintshwe sisibindi kubandakanya amitriptyline (Elavil), codeine, desipramine (Norpramin), flecainide (Tambocor), haloperidol (Haldol), imipramine (Tofranil), metoprolol (Lopressor, Toprol XL), ondansetron (Zofran), paroxetine (Paxiletine) ), risperidone (Risperdal), tramadol (Ultram), venlafaxine (Effexor), kunye nezinye.
Amayeza atshintshwe sisibindi (ICytochrome P450 3A4 (CYP3A4)
Amanye amayeza atshintshiwe kwaye aphulwe sisibindi. IBerberine inokunciphisa ngokukhawuleza ukuba isibindi siwaphula la mayeza kwaye sandise iziphumo kunye neziphumo ebezingalindelekanga. Amanye amayeza atshintshwe sisibindi kubandakanya i-cyclosporin (Neoral, Sandimmune), lovastatin (Mevacor), clarithromycin (Biaxin), indinavir (Crixivan), sildenafil (Viagra), triazolam (Halcion), kunye nabanye abaninzi.
Amayeza eswekile (iziyobisi zeAntidiabetes)
IBerberine isenokunciphisa iswekile esegazini. Amayeza eswekile asetyenziselwa ukunciphisa iswekile yegazi. Ukuthatha i-berberine kunye namayeza eswekile kunokubangela ukuba iswekile yegazi lakho lihle kakhulu. Jonga eswekile yegazi lakho ngokusondeleyo. Umthamo weyeza lakho leswekile unokufuna ukuba utshintshwe.

Amanye amayeza asetyenziselwa isifo seswekile aquka i-glimepiride (Amaryl), i-glyburide (i-Diabeta, i-Glynase PresTab, i-Micronase), i-insulin, i-pioglitazone (i-Actos), i-rosiglitazone (i-Avandia), kunye nezinye.
Amayeza oxinzelelo lwegazi oluphezulu (iziyobisi ezichasayo)
I-Berberine inokunciphisa uxinzelelo lwegazi kwabanye abantu. Ukuthatha iberberine kunye namayeza asetyenziselwa ukunciphisa uxinzelelo lwegazi kunokubangela ukuba uxinzelelo lwegazi luye phantsi kakhulu.

Amanye amayeza oxinzelelo lwegazi aphezulu abandakanya i-captopril (Capoten), enalapril (Vasotec), losartan (Cozaar), valsartan (Diovan), diltiazem (Cardizem), amlodipine (Norvasc), hydrochlorothiazide (HydroDIURIL), furosemide (Lasix), kunye nabanye abaninzi. .
Amayeza acothisa ukujiya kwegazi (iAnticoagulant / iziyobisi zeAntiplatelet)
IBerberine isenokucothisa ukujiya kwegazi. Ukuthatha i-berberine kunye namayeza acothisa ukucola kunokunyusa amathuba okugruzuka nokopha.

Amanye amayeza acothisa ukucoca igazi aquka iasprini, cilostazol (Pletal), clopidogrel (Plavix), dalteparin (Fragmin), enoxaparin (Lovenox), heparin, ticlopidine (Ticlid), kunye nezinye.
IMetformin (iGlucophage)
IBerberine inokunyusa inani le-metformin emzimbeni. Oku kunokunyusa iziphumo kunye neziphumo ebezingalindelekanga. Oku kunxibelelana kubonakala ngathi kwenzeka xa i-berberine ithathwa malunga neeyure ezi-2 ngaphambi kwe-metformin. Ukuthatha i-berberine kunye ne-metformin ngexesha elifanayo akubonakali kwandisa inani le-metformin emzimbeni.
Midazolam (iVenkile)
Umzimba uyaphula i-midazolam ukuyikhupha. I-Berberine inokunciphisa ukuba umzimba uyaphula ngokukhawuleza kangakanani kwaye inokunyusa iziphumo kunye neziphumo ebezingalindelekanga ze-midazolam.
IPentobarbital (iNembutal)
IPentobarbital sisiyobisi esinokubangela ubuthongo. IBerberine inokubangela ukozela nokozela. Ukuthatha i-berberine nge-pentobarbital kunokubangela ukulala kakhulu.
Amayeza okudambisa (i-CNS depressants)
IBerberine inokubangela ukulala nokozela. Amayeza abangela ubuthongo abizwa ngokuba kukuthomalalisa. Ukuthatha iberberine kunye namayeza okuthambisa kunokubangela ukulala kakhulu.

Amanye amayeza okuthambisa abandakanya i-benzodiazepines, ipentobarbital (Nembutal), phenobarbital (Luminal), secobarbital (Seconal), thiopental (Pentothal), fentanyl (Duragesic, Sublimaze), morphine, propofol (Diprivan), kunye nezinye.
ITacrolimus (iPrograf)
I-Tacrolimus sisiyobisi esingaxutywanga. Isuswe emzimbeni sisibindi. IBerberine inokunciphisa ukuba umzimba uyisusa ngokukhawuleza kangakanani kwaye oku kunokwandisa iziphumo kunye neziphumo ebezingalindelekanga zetacrolimus.
Iherbs kunye nezongezo ezinokunciphisa uxinzelelo lwegazi
IBerberine inokunciphisa uxinzelelo lwegazi. Ukuyisebenzisa kunye namanye amayeza kunye nezongezo ezinesiphumo esifanayo kunokunyusa umngcipheko wexinzelelo lwegazi oluwe phantsi kakhulu kwabanye abantu. Ezinye zezi mveliso zibandakanya i-andrographis, i-casein peptides, i-claw's claw, i-coenzyme Q-10, i-oyile yeentlanzi, i-L-arginine, i-lycium, i-nettle neting, i-theanine, kunye nezinye.
Iherbs kunye nezongezo ezinokunciphisa iswekile yegazi
IBerberine isenokunciphisa iswekile esegazini. Ukuyisebenzisa kunye namanye amayeza kunye nezongezo ezinefuthe elifanayo kunokubangela ukuba iswekile yegazi yehle kakhulu kwabanye abantu. Ezinye zeemveliso zibandakanya i-alpha-lipoic acid, i-melon ekrakra, i-chromium, i-devil's claw, i-fenugreek, i-garlic, i-guar gum, i-horse chestnut seed, i-Panax ginseng, i-psyllium, i-ginseng yaseSiberia, kunye nezinye.
Iherbs kunye nezongezo ezinokucothisa igazi
IBerberine isenokucothisa ukujiya kwegazi. Ukuthatha i-berberine kunye namanye amayeza anokunciphisa ukubamba kwegazi kunokunyusa amathuba okugruzuka nokopha. La mayeza afaka i-angelica, i-clove, i-danshen, igalikhi, ijinja, iginkgo, iPanax ginseng, kunye nabanye.
Iherbs kunye nezongezelelo ezineempawu zokuthomalalisa
IBerberine inokubangela ukulala okanye ukozela. Ukuyisebenzisa kunye namanye amayeza kunye nokuncedisa okunempembelelo efanayo kunokukwenza wozele ngokugqithiseleyo. Ezinye zale mifuno kunye nezongezelelo zibandakanya i-calamus, i-poppy yaseCalifornia, i-catnip, i-hops, i-dogwood yase-Jamaican, i-kava, i-L-tryptophan, i-melatonin, i-sage, i-SAMe, i-wort yase-St.
Iiprobiotic
Izongezo zeprobiotic ziqulathe iibhaktheriya ekucingelwa ukuba ziluncedo empilweni. IBerberine inokubulala iintlobo ezithile zeprobiotic. Ukuba ithathiwe kunye, i-berberine inokunciphisa indlela ezisebenza ngayo iiprobiotic supplements.
Akukho kunxibelelana kwaziwayo nokutya.
ABADALA

NGOMLOMO:
  • Isifo seswekile: I-0.9-1.5 yeegram zeberberine zithathiwe ngeedosi ezahlulwe yonke imihla kangangeenyanga ezi-2-4.
  • Amanqanaba aphezulu e-cholesterol okanye amanye amafutha (lipids) egazini (hyperlipidemia): I-0.6-1.5 iigram ze-berberine zithathiwe ngeedosi ezahlulwe yonke imihla iinyanga ezi-6 ukuya kwezi-24. Ukudityaniswa kweemveliso eziqulathe i-500 mg ye-berberine, i-10 mg ye-policosanol, kunye ne-200 mg yerayisi ebomvu, kunye nezinye izithako, zithathiwe yonke imihla ukuya kwiinyanga ezili-12.
  • Uxinzelelo lwegazi oluphezulu: 0.9 iigram zeberberine zithathiwe yonke imihla kangangeenyanga ezi-2.
  • Ukuphazamiseka kwehomoni okubangela ukwandisa ii-ovari kunye nee-cysts (polycystic ovary syndrome okanye iPCOS): 1.5 iigrem zeberberine zithathiwe yonke imihla iinyanga ezi-3-6.
Ukufaka isicelo kulusu:
  • Kwizilonda zomzimbaI-Gel equlathe i-5 mg ye-berberine ngegrama isetyenziswe kane ngemini kangangeentsuku ezintlanu.
Alcaloïde de Berbérine, Berberina, Berbérine, Berberine Alkaloid, Berberine Complex, Berberine Sulfate, Sulfate de Berbérine, Umbellatine.

Ukuze ufunde okungakumbi malunga nokubhalwa kweli nqaku, nceda ubone Amayeza endalo aVimba weDatha indlela yokusebenza.


  1. UAsbaghi ​​O, uGhanbari N, uShekari M, et al. Iziphumo zokuncediswa kwe-berberine kwiiparamitha zokutyeba kakhulu, ukudumba kunye nokusebenza kwe-enzyme yesibindi: uphononongo olucwangcisiweyo kunye nohlalutyo lweemeta zezilingo ezilawulwa ngokungahleliwe. Iiklinikhi zeZondlo ESPEN 2020; 38: 43-9. Jonga i-abstract.
  2. UChen YX, uGao QY, uZou TH, et al. I-Berberine xa ithelekiswa ne-placebo yothintelo lokuphindeka kwakhona kwe-adolo yecolorectal adenoma: i-multicentre, blind-blind, isifundo esilawulwa ngokungahleliwe. ILancet Gastroenterol iHepatol. Ngo-2020; 5: 267-75. Jonga i-abstract.
  3. U-Beba M, u-Djafarian K, u-Shab-Bidar S. Iziphumo ze-Berberine kwi-C-protein esebenzayo: uphononongo olucwangcisiweyo kunye nohlalutyo lweemeta zezilingo ezilawulwa ngokungahleliwe. Gcwalisa iTher Med. 2019; 46: 81-6. Jonga i-abstract.
  4. U-Lyu Y, uZhang Y, uYang M, et al. Ukudibana kwe-Pharmacokinetic phakathi kwe-metformin kunye ne-berberine kwiigundane: Indima yokulandelelana kolawulo lomlomo kunye ne-microbiota. Inzululwazi yoBomi. Ngo-2019; 235: 116818. Jonga i-abstract.
  5. UXu L, uZhang Y, uXue X, et al. Isigaba sokuqala sokuvavanywa kwe-berberine ngesiTshayina nge-ulcerative colitis. Umhlaza ngaphambili (Res) (Phila). Ngo-2020; 13: 117-26. Jonga i-abstract.
  6. UZhang LS, uZhang JH, uFeng R, et al. Ukusebenza kunye nokukhuseleka kwe-berberine yodwa okanye idityaniswe ne-statins kunyango lwe-hyperlipidemia: uphononongo olucwangcisiweyo kunye nohlalutyo lweemeta zovavanyo lweklinikhi olulawulwa ngokungacwangciswanga. NdinguJ Chin Med 2019; 47: 751-67. Jonga i-abstract.
  7. I-Qing Y, i-Dong X, i-Hongli L, i-Yanhui L. i-Berberine ikhuthaze ukukhuselwa kwe-myocardial yezigulana zasemva kokusebenza ngokulawula i-myocardial autophagy. Utywala ngogqirha. Ngo-2018; 105: 1050-1053. Jonga i-abstract.
  8. U-J J, u-Li J, u-Lin Q, u-Xu H. Ukusebenza kunye nokukhuseleka kwe-berberine kwi-dyslipidaemias: Uphengululo lwenkqubo kunye nohlalutyo lwe-meta lovavanyo lwezonyango olungenamsebenzi. Unyango lwezonyango. 2018; 50: 25-34. Jonga i-abstract.
  9. U-Li G, uZhao M, Qiu F, uSun Y, uZhao L.Ukusebenzisana kwe-Pharmacokinetic kunye nokunyamezelana kwe-berberine chloride kunye ne-simvastatin kunye ne-fenofibrate: ileyibhile evulekileyo, engahleliwe, yokufunda ngokufanayo kwizifundo ezinempilo zaseTshayina. Iziyobisi Des Desvel Ther. 2018; 13: 129-139. Jonga i-abstract.
  10. U-Yan HM, u-Xia MF, u-Wang Y, u-Chang XX, u-Yao XZ, u-Rao SX, et al. Ukusebenza kweBerberine kwizigulana ezinesifo esingenamafutha sesibindi. Inye. 2015 uAgasti 7; 10: e0134172. ikhonkco: 10.1371 / journal.pone.0134172. Jonga i-abstract.
  11. U-Chen C, uTao C, uLiu Z, uLu M, uPan Q, uZheng L, et al. Uvavanyo lweklinikhi olungenamkhethe lwe-berberine hydrochloride kwizigulana ezinesifo sorhudo esisifo esinganyanzelekanga. Phytother Res. NgoNovemba 2015; 29: 1822-7. ikhonkco: 10.1002 / ptr.5475. Jonga i-abstract.
  12. Wu XK, Wang YY, Liu JP, Liang RN, Xue HY, Ma HX, okqhubekayo. Uvavanyo olulawulwa ngokungahleliwe lwe-letrozole, i-berberine, okanye indibaniselwano yokungachumi kwi-polycystic ovary syndrome. Ukuchuma okuchumileyo. Ngo-2016; 106: 757-765.e1. ikhonkco: 10.1016 / j.fertnstert.2016.05.022. Jonga i-abstract.
  13. UZhang D, Ke L, Ni Z, Chen Y, Zhang LH, Zhu SH, okqhubekayo. I-Berberine equkethe unyango olunamacala amane e-Helicobacter pylori yokupheliswa: Ilebhile evulekileyo yokuvavanywa kwenqanaba lesine. Amayeza (iBaltimore). Ngo-2017; 96: e7697. ikhonkco: 10.1097 / MD.0000000000007697. Jonga i-abstract.
  14. UMarazzi G, uCampolongo G, uPelliccia F, uQuattrino S, uVitale C, uCacciotti L, et al. Ukuthelekiswa kwe-statin yedosi ephantsi xa kuthelekiswa nedermin yedosi esezantsi + iArmolipid kunye nezigulana ezinganyamezelekiyo ezinomnyhadala wecoronary kunye nongenelelo lwecoronary (ADHERENCE trial). NdinguJ Cardiol. 2017 Sep 15; 120: 893-897. ikhonkco: 10.1016 / j.amjcard.2017.06.015. Jonga i-abstract.
  15. UMarazzi G, uPelliccia F, uCampolongo G, uQuattrino S, uCacciotti L, uVolterrani M, et al. Ukusebenziseka kwe-nutraceuticals (Armolipid Plus) xa kuthelekiswa ne-ezetimibe kunye nokudityaniswa kwezigulana ezinganyamezeliyo ezinesifo se-dyslipidemia nesifo sentliziyo. NdinguJ Cardiol. Ngo-2015 uDisemba 15; 116: 1798-801. ikhonkco: 10.1016 / j.amjcard.2015.09.023. Jonga i-abstract.
  16. I-Wen C, Wu L, Fu L, Zhang X, Zhou H. Berberine yonyusa isenzo sokulwa nesifo se-tamoxifen kwi-MCF 7 eneziyobisi kunye neeseli ze-MCF 7 / TAM ezinganyangekiyo. Mol Mol Rep. 2016; 14: 2250-6. Jonga i-abstract.
  17. UMillán J, uCicero AF, uTorres F, uAnguera A. Iziphumo zokudityaniswa kwe-nutraceutical equlathe i-berberine (BRB), i-policosanol, kunye nerayisi ebomvu ye-rice (RYR), kwiprofayili ye-lipid kwizigulana ze-hypercholesterolemic. Iklinikhi yoPhando ngeArterioscler. Ngo-2016; 28: 178-87. Jonga i-abstract.
  18. UPérez-Rubio KG, uGonzález-Ortiz M, uMartínez-Abundis E, uRobles-Cervantes JA, u-Espinel-Bermúdez MC. Iziphumo zolawulo lwe-berberine kwi-metabolic syndrome, ubuntununtunu be-insulin, kunye nokugcinwa kwe-insulin. IMetab Syndr Relat Disord 2013; 11: 366-9. Jonga i-abstract.
  19. ILan J, Zhao Y, Dong F, et al. Ukutya Uhlalutyo lwe-meta lwesiphumo kunye nokukhuseleka kwe-berberine kunyango lwe-2 yeswekile, i-hyperlipemia kunye noxinzelelo lwegazi. J U-Ethnopharmacol. Ngo-2015; 161: 69-81. Jonga i-abstract.
  20. UJiang XW, uZhang Y, uZhu YL, et al. Iziphumo ze-berberine gelatin kwi-aphthous stomatitis ephindaphindayo: ulingo olungenamkhethe, olulawulwa yi-placebo, oluyimfama kabini kwiqela lamaTshayina. I-Oral Surg Oral Med Oral Pathol Oral Radiol 2013; 115: 212-7. Jonga i-abstract.
  21. IHou Q, uHan W, uFu X.Ukusebenzisana kwe-Pharmacokinetic phakathi kwe-tacrolimus kunye ne-berberine kumntwana one-idiopathic nephrotic syndrome. I-Eur J Clin Pharmacol 2013; 69: 1861-2. Jonga i-abstract.
  22. UDong H, Zhao Y, Zhao L, Lu F. Iziphumo ze-berberine kwi-lipids yegazi: uphononongo lwenkqubo kunye nohlalutyo lweemeta zezilingo ezilawulwa ngokungahleliwe. IPlanta Med 2013; 79: 437-46. Jonga i-abstract.
  23. U-Y, u-Sun Z, u-Zhang Y, u-Liu B, u-Guan Y, u-Lu M. Ukusetyenziswa kwe-berberine yabasetyhini abane-polycystic ovary syndrome ephantsi konyango lwe-IVF. Iklinikhi ye-Endocrinol (i-Oxf) 2014; 80: 425-31. Jonga i-abstract.
  24. U-Abascal K, uYarnell E. Ukuqhubela phambili kweklinikhi kwangoku nge-berberine. Enye into yokuGqibezela iTher 2010; 16: 281-7.
  25. Huang CG, Chu ZL, Wei SJ, Jiang H, Jiao BH. Iziphumo zeberberine kwi-arachidonic acid metabolism kwiiplatelets zomvundla kunye neeseli ze-endothelial. I-Thromb Res 2002; 106 (4-5): 223-7. Jonga i-abstract.
  26. Iwarber AJ. Ukuthatha ixesha elide njengeglucagon-peptide 1 receptor agonists: uphononongo lokusebenza kwabo kunye nokunyamezeleka. Unonophelo lweSwekile 2011; 34 iSuppl 2: S279-84. Jonga i-abstract.
  27. UCoughlan KA, uValentine RJ, uRuderman NB, uShaha AK. Ukwenza kusebenze i-AMPK: ngaba ekujolise kuko kunyango lwesifo seswekile sesi-2? Isifo seswekile iMetab Syndr Obes 2014; 7: 241-53. Jonga i-abstract.
  28. Unosilarha NJ, Minchin RF. I-Arylamine N-acetyltransferase 1: ithagethi yeziyobisi ekujoliswe kuyo kuphuhliso lomhlaza. Ukunyanga ngo-2012; 64: 147-65. Jonga i-abstract.
  29. URuscica M, uGomaraschi M, uMombelli G, uMacchi C, uBosisio R, uPazzucconi F, uPavanello C, uCalabresi L, uArnoldi A, uSirtori CR, uMagni P.Nutraceutical indlela yokumodareyitha umngcipheko we-cardiometabolic: iziphumo ze-randomized, blind-blind and crossover funda kunye neArmolipid Plus. J Ikliniki yeLipidol. Ngo-2014; 8: 61-8. Jonga i-abstract.
  30. URabbani G. Mechanism kunye nonyango lwesifo sorhudo ngenxa yeVibrio cholerae kunye ne-Escherichia coli: iindima zamachiza kunye neprostaglandins. I-Danish Bulletin yezoNyango 1996; 43: 173-185.
  31. I-Kaneda Y, Torii M, Tanaka T, kunye et al. Iziphumo ze-vitro ze-berberine sulphate ekukhuleni nakwimeko ye-Entamoeba histolytica, Giardia lamblia kunye neTrichomonas vaginalis. Izibhengezo zoNyango lweTropiki kunye noParasitology 1991; 85: 417-425.
  32. I-Saksena HC, i-Tomar VN, kunye ne-Soangra MR. Ukusebenza kwetyuwa entsha yeBerberine Uni-Berberine kwisifo saseMpuma. Ukuziqhelanisa noNyango ngoku 1970; 14: 247-252.
  33. I-Purohit SK, i-Kochar DK, i-Lal BB, kunye ne-al. Ukulinywa kweLeishmania tropica ukusuka kumatyala anganyangekiyo kunye nonyango lwempuma yesifo. Ijenali yaseIndiya yezeMpilo yoLuntu 1982; 26: 34-37.
  34. USharma R, uJoshi CK, kunye noGoyal RK. I-Berberine tannate kwisifo sohudo esibuhlungu. Iipediatrics zaseIndiya 1970; 7: 496-501.
  35. Li XB. [Ulawulo lweklinikhi olulawulwayo kwiintsana nasebantwaneni ngokuthelekisa i-Lacteol Fort sachets kunye neziyobisi ezibhekiselele kwi-antidiarrhoeal reference]. UAnn Pediatr 1995; 42: 396-401.
  36. ULahiri S kunye noDutta NK. I-Berberine kunye ne-chloramphenicol kunyango lwekholera kunye nohudo oluqatha. Ijenali yoMbutho Wezonyango waseIndiya 1967; 48: 1-11.
  37. IKamat SA. Uvavanyo lwezonyango nge-berberine hydrochloride yokulawula urhudo kwi-gastroenteritis ebukhali. J Assoc Amagqirha eIndiya 1967; 15: 525-529.
  38. IDutta NK kunye nePanse MV. Ukusetyenziswa kwe-berberine (i-alkaloid evela kwi-Berberis aristata) kunyango lwekholera (uvavanyo). Indiya J Med Res 1962; 50: 732-736.
  39. Wu, S. N., Yu, H. S., Jan, C. R., Li, H. F., kunye no Yu, C. L. Iziphumo zokuthintela i-berberine kwi-voltage- kunye ne-calcium-activated currents ye-potassium kwiiseli ze-myeloma zabantu. Ubomi beSayensi 1998; 62: 2283-2294. Jonga i-abstract.
  40. I-Ozaki, Y., Suzuki, H., kunye no-Satake, M. [Izifundo zokuthelekisa ukuxinaniswa kwe-berberine kwi-plasma emva kolawulo lomlomo lwe-coptidis rhizoma extract, iiseli zayo ezivelisiweyo, kunye nokusetyenziswa ngokudibeneyo kwezi zicatshulwa kunye ne-glycyrrhizae radix ekhutshwe kwiimpuku] . Yakugaku Zasshi 1993; 113: 63-69. Jonga i-abstract.
  41. Hu, F. L. [Thelekisa i-asidi kunye ne-Helicobacter pylori kwi-ulcerogenesis yesifo sezilonda zesisu]. Zhonghua Yi.Xue.Za Zhi. Ngo-1993; 73: 217-9, 253.
  42. Arana, B. A., Navin, T. R., Arana, F. E., Berman, J. D., kunye noRosenkaimer, F. Ukusebenza kwekhosi emfutshane (iintsuku ezili-10) zedosi ephezulu ye-meglumine antimonate kunye okanye ngaphandle kwe-interferon-gamma ekunyangeni i-leishmaniasis enqamlezileyo eGuatemala. Iiklinikhi ezichaphazela iDis 1994; 18: 381-384. Jonga i-abstract.
  43. UChekalina, S. I., Umurzakova, R. Z., uSaliev, K. K., kunye no-Abdurakhmanov, T. R. [Iziphumo ze-berberine bisulfate kwiplatelet hemostasis kwizigulana zethrombocytopenia]. IGematologiia iTransfuziologiia 1994; 39: 33-35. Jonga i-abstract.
  44. Ni, Y. X., Yang, J., kunye noFan, S. [Ufundo lwezonyango kwi-jiang tang san ekunyangeni abaguli abangaxhomekekanga kwi-insulin yesifo seswekile]. Zhongguo Zhong.Xi.Yi.Jie.Iye.Za Zhi. Ngo-1994; 14: 650-652. Jonga i-abstract.
  45. Kuo, C. L., Chou, C., Yung, B. Y. Berberine izakhiwo kunye ne-DNA kwi-berberine-induced apoptosis kwi-leukemic ye-HL-60. Umhlaza Lett 7-13-1995; 93: 193-200. Jonga i-abstract.
  46. UMiyazaki, H., Shirai, E., Ishibashi, M., Hosoi, K., Shibata, S., kunye no-Iwanaga, M. Ubungakanani be-berberine chloride kumchamo womntu ngokusetyenziswa kokhetho lwe-ion olukhethiweyo kwimowudi yokususa intsimi. Biomed.I-Spectrom yeMass. Ngo-1978; 5: 559-565. Jonga i-abstract.
  47. Babbar, O. P., Chhatwal, V. K., Ray, I. B., kunye noMehra, M. K. Iziphumo ze-berberine chloride yamehlo kwizigulana zetrachoma ezintle. Indiya J Med Res. 1982; 76 Ukuxhasa: 83-88. Jonga i-abstract.
  48. Mahajan, V. M., Sharma, A., kunye noRattan, A. Umsebenzi weAntimycotic we-berberine sulphate: ialkaloid evela kwiyeza laseIndiya. Sabouraudia. Ngo-1982; 20: 79-81. Jonga i-abstract.
  49. Mohan, M., Pant, C. R., Angra, S. K., kunye noMahajan, V. M. Berberine kwitrakoma. (Uvavanyo lweklinikhi). Indiya J Ophthalmol. Ngo-1982; 30: 69-75. Jonga i-abstract.
  50. UTai, Y.H, Feser, J. F., Marnane, W. G., kunye noDesjeux, J. F.Iziphumo ze-Antisecretory ze-berberine kwi-ile ile yeerat. NdinguJ Physiol 1981; 241: G253-G258. Jonga i-abstract.
  51. Chun YT, Yip TT, Lau KL, kunye et al. Isifundo se-biochemical kwimpembelelo ye-berberine kwiigundane. IGen Pharmac 1979; 10: 177-182. Jonga i-abstract.
  52. UDesai, A. B., Shah, K. M., kunye no-Shah, D. M. Berberine kunyango lohudo. Isilwanyana saseIndiya. Ngo-1971; 8: 462-465. Jonga i-abstract.
  53. Khin, Maung U., Myo, Khin, Nyunt, Nyunt Wai, Aye, Kyaw, kunye noTin, U. Uvavanyo lwezonyango lwe-berberine kuhudo olunamandla. UBr. Jonga i-abstract.
  54. Khin, Maung U., Myo, Khin, Nyunt, Nyunt Wai, kunye noTin, U. Uvavanyo lwezonyango lwe-berberine yedosi ephezulu kunye ne-tetracycline kwikholera. J Urhudo kwi-Dis Res. 1987; 5: 184-187. Jonga i-abstract.
  55. Thumm, H. W. kunye noTritschler, J. [Isenzo sika-Berberin-sehla kuxinzelelo lwangaphakathi (IOP) (ukuguqulelwa kombhali)]. I-Klin, iMonbl, iAugenheilkd. Ngowe-1977; 170: 119-123. Jonga i-abstract.
  56. UAlbal, M. V., Jadhav, S., kunye noChandorkar, A. G. Uvavanyo lwezonyango lwe-berberine kusulelo lwe-mycotic. Indiya J Ophthalmol. Ngo-1986; 34: 91-92. Jonga i-abstract.
  57. UWang, N., Feng, Y., Cheung, F., Chow, OY, Wang, X., Su, W., noTong, Y. Uphononongo lokuthelekisa isenzo se-hepatoprotective sebhere kunye neCoptidis Rhizoma Uvavanyo lwefibrosis yesibindi kwiigundane. I-BMC yokuGqibezela enye i-2012; 12: 239. Jonga i-abstract.
  58. I-Pisciotta, L., Bellocchio, A., kunye neBertolini, S. Ipilisi ye-Nutraceutical equlethe i-berberine kunye ne-ezetimibe kwiphethini ye-plasma lipid kwizifundo ze-hypercholesterolemic kunye nefuthe layo elongezelelweyo kwizigulane ezine-hypercholesterolemia yentsapho ekunciphiseni unyango lwe-cholesterol. I-Lipids yezeMpilo kwi-Dis 2012; 11: 123. Jonga i-abstract.
  59. Trimarco, V., Cimmino, CS, Santoro, M., Pagnano, G., Manzi, MV, Piglia, A., Giudice, CA, De, Luca N., kunye noIzzo, R.Izakhamzimba zolawulo lwexinzelelo lwegazi kwizigulana. ngoxinzelelo oluphezulu oluqhelekileyo okanye lwebanga 1. Uxinzelelo lwegazi oluphezulu Cardiovasc. I-9-1-2012; 19: 117-122. Jonga i-abstract.
  60. IHayasaka, S., Kodama, T., kunye no-Ohira, A. amayeza emveli aseJapan (ikampo) amayeza kunye nonyango lwezifo ze-ocular: uphononongo. NdinguJ Chin Med 2012; 40: 887-904. Jonga i-abstract.
  61. UHermann, R. kunye no-von, Richter O. Ubungqina beklinikhi yamachiza amayeza njengabenzi bokunxibelelana ngamachiza e-pharmacokinetic. IPlanta Med 2012; 78: 1458-1477. Jonga i-abstract.
  62. Hu, Y., Ehli, EA, Kittelsrud, J., Ronan, PJ, Munger, K., Downey, T., Bohlen, K., Callahan, L., Munson, V., Jahnke, M., Marshall, LL, Nelson, K., Huizenga, P., Hansen, R., Soundy, TJ, kunye noDavies, GE Lipid-ukwehlisa isiphumo se-berberine kwizifundo zabantu kunye neempuku. Unyango lwezonyango. 7-15-2012; 19: 861-867. Jonga i-abstract.
  63. ICarlomagno, G., Pirozzi, C., Mercurio, V., Ruvolo, A., kunye noFazio, S.Iziphumo zokudityaniswa kwe-nutraceutical kwindibaniselwano yasekhohlo ye-ventricular kunye ne-vasoreactivity kwizifundo ezinesifo se-metabolic syndrome. Isondlo Metab Cardiovasc. Dis 2012; 22: e13-e14. Jonga i-abstract.
  64. ICianci, A., Cicero, A. F., Colacurci, N., Matarazzo, M. G., kunye no-De, Leo, V. Umsebenzi we-isoflavones kunye ne-berberine kwiimpawu ze-vasomotor kunye neprofayili ye-lipid kubafazi abanesifo sokuya esikhathini. I-Gynecol kunye ne-Endocrinol. Ngo-2012; 28: 699-702. Jonga i-abstract.
  65. Xie, X., Meng, X., Zhou, X., Shu, X., kunye noKong, H. [Uphando malunga nefuthe lokunyanga kunye nokutshintsha kwesifo se-hemorrheology se-berberine kwizigulana ezitsha ezifumanekayo ezinesifo seswekile esidibanisa isifo esinamafutha sesibindi]UZhongguo Zhong Yao Za Zhi 2011; 36: 3032-3035. Jonga i-abstract.
  66. Meng, S., Wang, L. S., Huang, Z. Q., Zhou, Q., Sun, Y. G., Cao, J. T., Li, Y. G., kunye noWang, C. Q. IBerberine ikhuthaza ukudumba kwizigulana ezine-acon coronary syndrome kulandela ungenelelo lwecoronary. Uvavanyo lweklinikhi. Pharmacol Physiol 2012; 39: 406-411. Jonga i-abstract.
  67. UKim, H. S., Kim, M. J., Kim, E. J., Yang, Y., Lee, M. S., kunye noLim, J. S. Berberine-owenza ukuba kusebenze i-AMPK kuthintele amandla e-metastatic kwiiseli ze-melanoma ngokunciphisa umsebenzi we-ERK kunye ne-COX-2 protein expression. Biochem. IPharmacol 2-1-2012; 83: 385-394. Jonga i-abstract.
  68. UMarazzi, G., Cacciotti, L., Pelliccia, F., Iaia, L., Volterrani, M., Caminiti, G., Sposato, B., Massaro, R., Grieco, F., kunye noRosano, G. Iziphumo zexesha elide ze-nutraceuticals (i-berberine, imvubelo ebomvu irayisi, i-policosanol) kwizigulana ezinesifo esikhulileyo. U-Adv. 2011; 28: 1105-1113. Jonga i-abstract.
  69. Wei, W., Zhao, H., Wang, A., Sui, M., Liang, K., Deng, H., Ma, Y., Zhang, Y., Zhang, H., kunye noGuan, Y. Isifundo seklinikhi kwimpembelelo yexesha elifutshane ye-berberine xa kuthelekiswa ne-metformin kwiimpawu ze-metabolic yabasetyhini abane-polycystic ovary syndrome. I-Eur J Endocrinol. Ngo-2012; 166: 99-105. Jonga i-abstract.
  70. UWang, Q., Zhang, M., Liang, B., Shirwany, N., Zhu, Y., kunye noZou, MH Ukwenza ukuba i-AMP isebenze ngeprotein kinase iyafuneka ekunciphiseni i-berberine-indased ukunciphisa i-atherosclerosis kwiimpuku: indima ye-protein engadibaniyo 2. I-PLoS.One. Ngo-2011; 6: e25436. Jonga i-abstract.
  71. Guo, Y., Chen, Y., Tan, Z. R., Klaassen, C. D., kunye noZhou, H. H. Ulawulo oluphindaphindiweyo lwe-berberine inhibits cytochromes P450 ebantwini. I-Eur J Clin Pharmacol 2012; 68: 213-217. Jonga i-abstract.
  72. IMvana, JJ, Holick, MF, Lerman, RH, Konda, VR, Minich, DM, Desai, A., Chen, TC, Austin, M., Kornberg, J., Chang, JL, Hsi, A., Bland, I-JS, kunye neTripp, i-ML yokondla isondlo se-hop rho iso-alpha acids, i-berberine, i-vitamin D, kunye ne-vitamin K ivelisa iphrofayili ye-bone biomarker efanelekileyo exhasa i-bone metabolism ye-metabolism kubafazi be-postmenopausal abane-syndrome. Ukutya okunesondlo ngo-2011; 31: 347-355. Jonga i-abstract.
  73. Holick, MF, iMvana, JJ, Lerman, RH, Konda, VR, Darland, G., Minich, DM, Desai, A., Chen, TC, Austin, M., Kornberg, J., Chang, JL, Hsi, A., Bland, JS, kunye neTripp, i-ML Hop rho iso-alpha acids, i-berberine, i-vitamin D3 kunye ne-vitamin K1 ifuthe elihle kwi-biomarkers ye-bone turnover kubafazi be-postmenopausal kwisilingo seveki ezili-14. J Bone Miner, iMetab 2010; 28: 342-350. Jonga i-abstract.
  74. UZhang, H., Wei, J., Xue, R., Wu, JD, Zhao, W., Wang, ZZ, Wang, SK, Zhou, ZX, Ingoma, DQ, Wang, YM, Pan, HN, Kong, I-WJ, kunye ne-Jiang, i-JD Berberine yehlisa i-glucose yegazi kuhlobo lwe-2 yesifo seswekile ngokunyusa ukubonakaliswa kwe-insulin. Imetabolism 2010; 59: 285-292. Jonga i-abstract.
  75. UWang, Y., Jia, X., Ghanam, K., Beaurepaire, C., Zidichouski, J., kunye noMiller, uL.Berberine kunye nezityalo zestanols ngokuhambelana zithintela ukufunxwa kwe-cholesterol kwiihamsters. I-Atherosclerosis 2010; 209: 111-117. Jonga i-abstract.
  76. Li, GH, Wang, DL, Hu, YD, Pu, P., Li, DZ, Wang, WD, Zhu, B., Hao, P., Wang, J., Xu, XQ, Wan, JQ, Zhou, I-YB, kunye ne-Chen, i-ZT Berberine inqanda isifo esibuhlungu samathumbu emathunjini emntwini onesisu esiswini. IMed Oncol. Ngo-2010; 27: 919-925. Jonga i-abstract.
  77. Affuso, F., Ruvolo, A., Micillo, F., Sacca, L., kunye noFazio, S.Iziphumo zokudityaniswa kwe-nutraceutical (i-berberine, irayisi ebomvu ilayisi kunye neepolisosanols) kumanqanaba e-lipid kunye nokusebenza kwe-endothelial ngokulandelelana, okungaboniyo kabini , isifundo esilawulwa yi-placebo. Isondlo Metab Cardiovasc. Dis 2010; 20: 656-661. Jonga i-abstract.
  78. UJeong, H. W., Hsu, K. C., Lee, J. W., Ham, M., Huh, J. Y., Shin, H. J., Kim, W. S., kunye noKim, uJ. B. Berberine bacinezela iimpendulo ezinokubakho ngokusebenza kwe-AMPK kwii-macrophages. NdinguJ Physiol Endocrinol. IMetab 2009; 296: E955-E964. Jonga i-abstract.
  79. UKim, WS, Lee, YS, Cha, SH, Jeong, HW, Choe, SS, Lee, MR, Oh, GT, Park, HS, Lee, KU, Lane, MD, kunye noKim, uJB Berberine uphucula ukudakumba kwe-lipid ekutyebeni kakhulu ngokulawula umbindi kunye nomda womsebenzi we-AMPK. NdinguJ Physiol Endocrinol. IMetab 2009; 296: E812-E819. Jonga i-abstract.
  80. Lu, SS, Yu, YL, Zhu, HJ, Liu, XD, Liu, L., Liu, YW, Wang, P., Xie, L., noWang, GJ Berberine ikhuthaza i-peptide-1 yeglucagon-1 (7- 36) ukugcinwa kwemfihlo kwiigundane zesifo seswekile esenziwe nge-streptozotocin. J Endocrinol. Ngo-2009; 200: 159-165. Jonga i-abstract.
  81. Liu, Y., Yu, H., Zhang, C., Cheng, Y., Hu, L., Meng, X., kunye noZhao, Y. Iziphumo zokukhusela i-berberine kwingozi yemiphunga ebangelwa yimitha ngokusebenzisa i-intercellular adhesion molecular- 1 kunye nokuguqula ukukhula kwe-beta-1 kwizigulana ezinomhlaza wemiphunga. Umhlaza we-Eur J 2008; 44: 2425-2432. Jonga i-abstract.
  82. I-Yang, Z., Shao, YC, Li, SJ, Qi, JL, Zhang, MJ, Hao, W., kunye noJin, GZ Amayeza e-l-tetrahydropalmatine aphucula kakhulu umnqweno we-opiate kwaye andise izinga lokuthintela abasebenzisi be-heroin: umqhubi wenqwelomoya ukufunda. Acta Pharmacol Isono. Ngo-2008; 29: 781-788. Jonga i-abstract.
  83. Zhou, JY, Zhou, SW, Zhang, KB, Tang, JL, Guang, LX, Ying, Y., Xu, Y., Zhang, L., noLi, DD Iziphumo ezingapheliyo ze-berberine egazini, kwisibindi glucolipid metabolism kunye Ukubonisa isibindi kwi-PPARs kwisifo seswekile kwiigundane ze-hyperlipidemic. IBiol Pharm Bull. Ngo-2008; 31: 1169-1176. Jonga i-abstract.
  84. U-Yin, J., Xing, H., kunye no-E, uJ. Ukusebenza kwe-berberine kwizigulana ezinesifo seswekile sesifo seswekile. Imetabolism 2008; 57: 712-717. Jonga i-abstract.
  85. UZhang, Y., Li, X., Zou, D., Liu, W., Yang, J., Zhu, N., Huo, L., Wang, M., Hong, J., Wu, P., URen, G., no-Ning, G. Unyango lohlobo 2 lweswekile kunye nedyslipidemia ngesityalo sendalo i-alkaloid berberine. J Clin Endocrinol. Imethab 2008; 93: 2559-2565. Jonga i-abstract.
  86. I-Xu, M. G., Wang, J. M., Chen, L., Wang, Y., Yang, Z., kunye neTao, J. Berberine-indibilizi yokuqhubela phambili ukujikeleza kweeseli zenzala ephucula amandla emithambo yabantu. J Hum. Hypertens 2008; 22: 389-393. Jonga i-abstract.
  87. I-Xin, H. W., Wu, X., Li, Q., Yu, A. R., Zhong, M. Y., kunye noLiu, Y. Iziphumo ze-berberine kwi-pharmacokinetics ye-cyclosporin A kumavolontiya asempilweni. Iindlela zokufumana iExp.Clin Pharmacol 2006; 28: 25-29. Jonga i-abstract.
  88. UMantena, S. K., uSharma, uS. D., noKatiyar, uS. K. Berberine, imveliso yendalo, inciphisa ukubanjwa komjikelo weseli ye-G1 kunye ne-caspase-3-exhomekeke kwi-apoptosis kwiiseli zeprotate carcinoma yabantu. Umhlaza weCancer Ther 2006; 5: 296-308. Jonga i-abstract.
  89. I-Lin, C. C., Kao, S., Chen, G. W., Ho, H., kunye no Chung, J. G. Apoptosis ye-leukemia yabantu HL-60 iiseli kunye ne-murine leukemia iiseli ze-WEHI-3 ezibangelwa yi-berberine ngokusebenzisa i-caspase-3. I-Anticancer Res 2006; 26 (1A): 227-242. Jonga i-abstract.
  90. I-Lin, J. P., Yang, J. S., Lee, J. H., Hsieh, W. T., kunye no Chung, J. G. Berberine inducse cell cell arrest and apoptosis in gastric carcinoma SNU-5 line cell. Kwihlabathi J Gastroenterol. 1-7-2006; 12: 21-28. Jonga i-abstract.
  91. Inoue, K., Kulsum, U., Chowdhury, S. A., Fujisawa, S., Ishihara, M., Yokoe, I., noSakagami, H. Tumor-ekhethekileyo i-cytotoxicity kunye ne-apoptosis-ekhuthaza umsebenzi weeberberines. I-Anticancer Res 2005; 25 (6B): 4053-4059. Jonga i-abstract.
  92. U-Lee, S., Lim, H. J., Park, H. Y., Lee, K. S., Park, J. H., kunye noJang, Y. Berberine inhibits rat rat vascular smooth cell cell proliferation and migration in vitro kwaye iphucula ukwakheka kwe-neointima emva kokonzakala kwebhaluni kwi vivo. IBerberine iphucula ukwenziwa kwe-neointima kwimodeli yeempuku. I-Atherosclerosis 2006; 186: 29-37. Jonga i-abstract.
  93. Kuo, C. L., Chi, C. W., kunye noLiu, T. Y. Ukuguqulwa kwe-apoptosis yi-berberine ngokuthintela i-cyclooxygenase-2 kunye ne-Mcl-1 expression kwiiseli zomhlaza womlomo. KwiVivo 2005; 19: 247-252. Jonga i-abstract.
  94. Kong, W., Wei, J., Abidi, P., Lin, M., Inaba, S., Li, C., Wang, Y., Wang, Z., Si, S., Pan, H., UWang, S., Wu, J., Wang, Y., Li, Z., Liu, J., noJiang, uJD Berberine sisiyobisi esinciphisa i-cholesterol esisebenza ngendlela ekhethekileyo eyahlukileyo kwimithetho. Nat Med 2004; 10: 1344-1351. Jonga i-abstract.
  95. Yount, G., Qian, Y., Moore, D., Basila, D., West, J., Aldape, K., Arvold, N., Shalev, N., kunye noHaas-Kogan, D. Berberine yazisa abantu iiseli ze-glioma, kodwa hayi iiseli eziqhelekileyo ze-glial, ukuya kwimitha ye-ionizing kwi-vitro. J Exp Ther Oncol. Ngo-2004; 4: 137-143. Jonga i-abstract.
  96. I-Lin, S., Tsai, S. C., Lee, C. C., Wang, B. W., Liou, J. Y., kunye no-Shyu, K. G. Berberine inqanda intetho ye-HIF-1alpha ngeproteolysis eyandisiweyo. UMol Pharmacol 2004; 66: 612-619. Jonga i-abstract.
  97. UNishida, S., Kikuichi, S., Yoshioka, S., Tsubaki, M., Fujii, Y., Matsuda, H., Kubo, M., kunye no-Irimajiri, K.Ukwenziwa kweapoptosis kwii-HL-60 iiseli eziphathwe ngayo amayeza amayeza. NdinguJ Chin Med 2003; 31: 551-562. Jonga i-abstract.
  98. Iizuka, N., Oka, M., Yamamoto, K., Tangoku, A., Miyamoto, K., Miyamoto, T., Uchimura, S., Hamamoto, Y., kunye no-Okita, K. Ukuchongwa kwezinto eziqhelekileyo okanye ezahlukileyo. Imfuza enxulumene nemisebenzi ye-antitumor yeyeza elinamayeza kunye neyona nto iphambili kuyo yi-oligonucleotide microarray. Int J Umhlaza 11-20-2003; 107: 666-672. Jonga i-abstract.
  99. UJantova, S., Cipak, L., Cernakova, M., kunye noKost'alova, D. Iziphumo ze-berberine ekwandeni, kumjikelo weseli kunye ne-apoptosis kwii-HeLa nakwiiseli ze-L1210. J Pharm Pharmacol 2003; 55: 1143-1149. Jonga i-abstract.
  100. Hong, Y., Hui, S. S., Chan, B.T, kunye noHou, J. Iziphumo zeberberine kumanqanaba e-catecholamine kwiigundane ezinesilingo sehypertrophy yentliziyo. Inzululwazi yoBomi. 4-18-2003; 72: 2499-2507. Jonga i-abstract.
  101. UWang, DY, Yeh, CC, Lee, JH, Hung, CF, noChung, uJG Berberine uthintele umsebenzi we-arylamine N-acetyltransferase kunye nokubonakaliswa kofuzo kunye nokwenziwa kwe-DNA ekwenziweni kwe-astrocytoma enobungozi (G9T / VGH) kunye nengqondo glioblastoma multiforms (GBM 8401 iiseli. Neurochem. I-2002; 27: 883-889 (PubMed) (Umnqamlezo) Jonga i-abstract.
  102. ISriwilaijareon, N., Petmitr, S., Mutirangura, A., Ponglikitmongkol, M., kunye neWilairat, P. Inqanaba elithile lePlasmodium falciparum telomerase kunye nokuthintelwa kwayo yi-berberine. IParasitol. Int 2002; 51: 99-103. Jonga i-abstract.
  103. I-Pan, J. F., Yu, C., Zhu, D. Y., Zhang, H., Zeng, J. F., Jiang, S. H., kunye no-Ren, J. Y. Ukuchongwa kweemetabolites ezintathu ze-sulfate-conjugated metabolites ze-berberine chloride kumchamo wamavolontiya asempilweni emva kolawulo lomlomo. Acta Pharmacol Isono. Ngo-2002; 23: 77-82. Jonga i-abstract.
  104. I-Soffar, S. A., Metwali, D. M., Abdel-Aziz, S. S., el Wakil, H. S., kunye ne-Saad, G. A. Ukuvavanywa kwesiphumo se-alkaloid yesityalo (i-berberine ethathwe kwi-Berberis aristata) kwi-Trichomonas vaginalis in vitro. J iYiputa, iSoc Parasitol. 2001; 31: 893-904. Jonga i-abstract.
  105. Inbaraj, J. J., Kukielczak, B. M., Bilski, P., Sandvik, S. L., noChignell, C. F. Photochemistry kunye nefotocytotoxicity yee-alkaloids ezivela eGoldenseal (Hydrastis canadensis L.) 1. Berberine. I-Chem Res Toxicol 2001; 14: 1529-1534 (PubMed) (Umnqamlezo) Jonga i-abstract.
  106. Wright, C.W, Marshall, S. J., Russell, P.F, Anderson, M. M., Phillipson, J. D., Kirby, G. C., Warhurst, D. C., kunye no-Schiff, P. L. In vitro antiplasmodial, antiamoebic, kunye ne-cytotoxic imisebenzi yezinye i-monomeric isoquinoline alkaloids. J Nat Prod 2000; 63: 1638-1640. Jonga i-abstract.
  107. U-Hu, J. P., Takahashi, N., kunye no-Yamada, T. Coptidis rhizoma inqanda ukukhula kunye neeproteases zebacteria yomlomo. Umlomo Dis. Ngo-2000; 6: 297-302. Jonga i-abstract.
  108. Chung, JG, Chen, GW, Hung, CF, Lee, JH, Ho, CC, Ho, HC, Chang, HL, Lin, WC, kunye neLin, JG Iziphumo zeberberine kwimisebenzi ye-arylamine N-acetyltransferase kunye ne-2-aminofluorene- Ukwenziwa kwe-DNA ekwakheni iiseli ze-leukemia yabantu. NdinguJ Jin Med 2000; 28: 227-238. Jonga i-abstract.
  109. IBerberine. Enye iMed Rev 2000; 5: 175-177. Jonga i-abstract.
  110. Iizuka, N., Miyamoto, K., Okita, K., Tangoku, A., Hayashi, H., Yosino, S., Abe, T., Morioka, T., Hazama, S., kunye no-Oka, M. Isithintelo sokusebenza kweCoptidis Rhizoma kunye ne-berberine ekwandeni kwemigca yeseli yomhlaza womntu. Umhlaza Lett 1-1-2000; 148: 19-25. Jonga i-abstract.
  111. Chae, S.H, Jeong, I.H, Choi, D.H, Oh, J. W., kunye no-Ahn, Y.J.Iziphumo ezithintela ukukhula kweCoptis japonica i-isoquinoline alkaloids evela kwiibhakteria zamathumbu abantu. Ukutya uKhem 1999; 47: 934-938. Jonga i-abstract.
  112. UZeng, X. kunye noZeng, X.Ubudlelwane phakathi kweziphumo zeklinikhi ze-berberine kwisifo sentliziyo esomeleleyo kunye noxinzelelo lwayo kwi-plasma efundwe yi-HPLC. I-Biomed yeChromatogr 1999; 13: 442-444. Jonga i-abstract.
  113. I-Lin, J. G., Chung, J. G., Wu, L.T, Chen, G. W., Chang, H. L., kunye no-Wang, T. F. Iziphumo ze-berberine kwi-arylamine N-acetyltransferase yomsebenzi kwiiseli zetyum. NdinguJ Jin Med 1999; 27: 265-275. Jonga i-abstract.
  114. I-Chung, JG, Wu, LT, Chu, CB, Jan, JY, Ho, CC, Tsou, MF, Lu, HF, Chen, GW, Lin, JG, kunye noWang, Iziphumo ze-TF ze-berberine kwi-arylamine N-acetyltransferase iiseli zesisu zesisu somntu. Ukutya Chem Toxicol 1999; 37: 319-326. Jonga i-abstract.
  115. Wu, H. L., Hsu, C. Y., Liu, W. H., kunye no-Yung, B. Y. Berberine-indopoposis yesifo segazi lomntu I-HL-60 iiseli zinxulunyaniswa nolawulo olusezantsi lwe-nucleophosmin / B23 kunye nomsebenzi we-telomerase. Int J Umhlaza 6-11-1999; 81: 923-929. Jonga i-abstract.
  116. Ilanga D, iCourtney HS, kunye neBeachey EH. I-Berberine sulphate ibhloka ukubambelela kwe-Streptococcus pyogenes kwiiseli ze-epithelial, i-fibronectin, kunye ne-hexadecane. Iiarhente zeAntimicrobial kunye neChemotherapy 1988; 32: 1370-1374.
  117. Palasuntheram C, Iyer KS, de Silva LB, kunye et al. Umsebenzi we-Antibacterial weCoscinium fenestratum Colebr ngokuchasene neClostridium tetani. Ind J Med Res 1982; 76 (iSuppl): 71-76.
  118. UZhu B kunye no-Ahrens FA. Iziphumo zeberberine kwimfihlo yamathumbu ethunyelwe ngu-Escherichia coli ubushushu obuzinzileyo be-enterotoxin kwijejunum yeehagu. NdinguJ Vet Res 1982; 43: 1594-1598.
  119. Supek Z kunye noTomic D. Farmakološko-kemijsko istrazivanje zutike (
  120. UZalewski A, Krol R, kunye noMaroko PR. I-Berberine, iarhente ye-inotropic entsha-umahluko phakathi kwempendulo yentliziyo kunye nomda. Iklinikhi Res 1983; 31: 227A.
  121. UKrol R, uZalewski A, kunye noMaroko PR. Iziphumo eziluncedo ze-berberine, iarhente elungileyo ye-inotropic, kwi-digitalis-induction ventricular arrhythmias. Ukujikeleza kwe-1982; 66 (suppl 2): ​​56.
  122. Subbaiah TV kunye no-Amin AH. Iziphumo ze-berberine sulphate kwi-Entamoeba histolytica. Uhlobo lwango-1967; 215: 527-528.
  123. I-Kaneda Y, Tanaka T, kunye ne-Saw T. Iziphumo ze-berberine, isityalo se-alkaloid, ekukhuleni kwe-anaerobic protozoa kwinkcubeko ye-axenic. I-Tokai J Exp Clin kwi-1990; 15: 417-423.
  124. IGhosh AK, iBhattacharyya FK, kunye neGhosh DK. I-Leishmania donovani: inastigote inhibition kunye nendlela yokusebenza kweberberine. Uvavanyo lweParasitology 1985; 60: 404-413.
  125. USabir M, Mahajan VM, Mohapatra LN, kunye no-al. Uvavanyo lokuvavanya isenzo se-antitrachoma se-berberine. Indiya J Med Res 1976; 64: 1160-1167.
  126. I-Seery TM kunye neBieter RN. Igalelo kwi-pharmacology ye-berberine. UJ Pharmacol Exp Ther 1940; 69: 64-67.
  127. Uhambo lwe-YB kunye ne-Shukla SD. IBerberis artistata inqanda ukuhlanganiswa kweeplatelet zemvundla. UPhando lwePhytotherapy 1996; 10: 628-630.
  128. USabir M kunye noBhide NK. Ukufundwa kwezinye zezinto ezenziwa ngamayeza e-berberine. I-Ind J Physiol kunye neFarmac 1971; 15: 111-132.
  129. UChung JG, Wu LT, Chang SH, kunye et al. Amanyathelo okuthintela i-berberine ekukhuleni kunye nomsebenzi we-arylamine N-acetyltransferase kwiintlobo zeHelicobacter Pylori kwizigulana ezinesilonda esiswini. Ijenali yaMazwe ngaMazwe yeToxicology 1999; 18: 35.
  130. I-Sharda DC. I-Berberine kunyango lwesifo sohudo ebusaneni nasebuntwaneni. J Indiya M A 1970; 54: 22-24.
  131. UVik-Mo H, Faria DB, Cheung WM, kunye et al. Iziphumo eziluncedo zeBerberine ekusebenzeni kwe-ventricular yasekhohlo ezinjeni ezinesifo sentliziyo. Uphando lweklinikhi 1983; 31: 224a.
  132. I-Ksiezycka E, Cheung W, kunye neMaroko PR. Iziphumo ezinxamnye ne-antiarrhythmic ze-berberine kwi-aconitine-induction ventricular kunye ne-supraventricular arrhythmias. Uphando lweklinikhi 1983; 31: 197A.
  133. Jonga i-WK, iFerrante A, iiSummers A, kunye et al. Iziphumo zokuthelekisa itetrandrine kunye ne-berbamine kwimveliso yee-cytokines ezivuthayo ze-interleukin-1 kunye ne-tumor necrosis factor. IiSayensi zoBomi 1992; 50: pl-53-pl-58.
  134. UPeng, W.H, Hsieh, M.T, noWu, C. R. Iziphumo zolawulo lwexesha elide lwe-berberine kwi-scopolamine-indened amnesia kwiigundane. Ijpn J Pharmacol 1997; 74: 261-266. Jonga i-abstract.
  135. Wu, J. F. kunye no-Liu, T. P. [Iziphumo ze-berberine kwi-platelet aggregation kunye ne-plasma level ye-TXB2 kunye ne-6-keto-PGF1 i-alpha kwiigundane ezinokubuyiswa komthambo ophakathi wobuchopho]. Yao Xue.Xue.Bao. 1995; 30: 98-102. Jonga i-abstract.
  136. Yuan, J., Shen, X. Z., kunye noZhu, X. S. [Iziphumo zeberberine ngexesha lokuhamba lamathumbu amancinci omntu]. Zhongguo Zhong.Xi.Yi.Jie.Iye.Za Zhi. Ngo-1994; 14: 718-720. Jonga i-abstract.
  137. UMuller, K., Ziereis, K., kunye noGawlik, I. I-antipsoriatic Mahonia aquifolium kunye nezinto zayo ezisebenzayo; II. Umsebenzi we-Antiproliferative ngokuchasene nokukhula kweseli kweekeratinocytes zabantu. UPlanta Med 1995; 61: 74-75. Jonga i-abstract.
  138. I-Swabb, E. A., Tai, YH, kunye neJordani, L.Ukubuyiselwa umva kwecholera kwi-rat ileum yi-luminal berberine. NdinguJ Physiol 1981; 241: G248-G252. Jonga i-abstract.
  139. USack, R. B. kunye noFroehlich, J. L. Berberine uthintela impendulo eyimfihlo yamathumbu emathunjini eVibrio cholerae kunye ne-Escherichia coli enterotoxin. Yosulela Immun. Ngo-1982; 35: 471-475. Jonga i-abstract.
  140. UZhu, B. kunye no-Ahrens, F. Iziphumo ze-Antisecretory ze-berberine ene-morphine, i-clonidine, i-L- phenylephrine, yohimbine okanye neostigmine kwihagu jejunum. I-Eur J Pharmacol 12-9-1983; 96 (1-2): 11-19. Jonga i-abstract.
  141. UShanbhag, S. M., Kulkarni, H. J., kunye noGaitonde, B. B. Izenzo zamachiza e-berberine kwinkqubo ye-nervous system. Jpn. J Pharmacol 1970; 20: 482-487 (PubMed) (Umnqamlezo) Jonga i-abstract.
  142. IChoudhry, V. P., Sabir, M., kunye neBhide, V. N. Berberine kwi-giardiasis. Isilwanyana saseIndiya. Ngo-1972; 9: 143-146. Jonga i-abstract.
  143. Kulkarni, S. K., Dandiya, P. C., kunye noVarandani, N. L.Uphando lwe-Pharmacological ye-berberine sulphate. Jpn. J iPharmacol. Ngo-1972; 22: 11-16. Jonga i-abstract.
  144. UMarin-Neto, uJ., Maciel, uB, C., uSecches, uA. L., noGallo, uJunior L. Iziphumo zentliziyo ye-berberine kwizigulana ezinesifo sentliziyo esomeleleyo. KwiKlinikhi. Ngo-1988; 11: 253-260. Jonga i-abstract.
  145. Ni, Y. X. [Iziphumo zonyango lwe-berberine kwizigulana ezingama-60 zohlobo lweswekile lwesifo seswekile kunye nophando lokulinga]. UZhong.Xi.Yi.Jie.He.Za Zhi.- Ijenali yaseTshayina yoPhuculo lwale mihla kunyango lweNdabuko ngo-1988; 8: 711-3, 707.
  146. UZhang, M. F. kunye no-Shen, Y. Q. [Iziphumo ze-Antidiarrheal kunye ne-anti-inflammatory ye-berberine]. Zhongguo Yao Li Xue.Bao. Ngo-1989; 10: 174-176. Jonga i-abstract.
  147. Shaffer, J. E. Inotropic kunye nomsebenzi we-chronotropic we-berberine kwi-guinea pig atria eyahlukileyo. J Cardiovasc Pharmacol 1985; 7: 307-315 (PubMed) (Umnqamlezo) Jonga i-abstract.
  148. Huang, W. M., Wu, Z. D., kunye noGan, Y. Q. [Iziphumo ze-berberine kwi-ischemic ventricular arrhythmia]. Zhonghua Xin.Xue.Guan.Bing.Za Zhi. 1989; 17: 300-1, 319. Jonga i-abstract.
  149. Huang, W.[I-Ventricular tachyarrhythmias iphathwe nge-berberine]. Zhonghua Xin.Xue.Guan.Bing.Za Zhi. Ngo-1990; 18: 155-6, 190.
  150. UHui, K. K., Yu, J. L., Chan, W. F., no-Tse, E. Ukudibana kwe-berberine kunye neplatelet yabantu i-alpha 2 adrenoceptors. Inzululwazi yoBomi. Ngo-1991; 49: 315-324. Jonga i-abstract.
  151. I-Freile, ML, Giannini, F., Pucci, G., Sturniolo, A., Rodero, L., Pucci, O., Balzareti, V., kunye no-Enriz, umsebenzi we-RD we-Antimicrobial of aqueous extracts kunye ne-berberine eyahlukaniswa ne-Berberis heterophylla . UFitoterapia 2003; 74 (7-8): 702-705. Jonga i-abstract.
  152. Khin, Maung U. kunye noNwe, Nwe Wai. Iziphumo zeberberine kwi-enterotoxin-indased intestinal fluid ukuqokelela kwiigundane. J Urhudo kwi-Dis Res 1992; 10: 201-204. Jonga i-abstract.
  153. IHajnicka, V., Kost'alova, D., Svecova, D., Sochorova, R., Fuchsberger, N., kunye noToth, J. Iziphumo zeMahonia aquifolium iikhompawundi ezisebenzayo kwimveliso ye-interleukin-8 kwilayini yeseli ye-monocytic yabantu THP -1. IPlanta Med 2002; 68: 266-268. Jonga i-abstract.
  154. Lau, C. W., Yao, X. Q., Chen, Z. Y., Ko, W. H., kunye noHuang, Y. Izenzo zentliziyo ye-berberine. ICardiovasc iziyobisi ngo-2001; 19: 234-244. Jonga i-abstract.
  155. UMitani, N., Murakami, K., Yamaura, T., Ikeda, T., kunye noSaiki, I. Isiphumo sokuthintela i-berberine kwi-lymph node metastasis ye-mediastinal eveliswa kukufakwa kwe-orthotopic ye-lung lung carcinoma. Umhlaza Lett. 4-10-2001; 165: 35-42. Jonga i-abstract.
  156. UFukuda, K., Hibiya, Y., Mutoh, M., Koshiji, M., Akao, S., kunye noFujiwara, H. Inhibition yi-berberine ye-cyclooxygenase-2 yomsebenzi okhutshelweyo kwiiseli zomhlaza womntu. J U-Ethnopharmacol. Ngo-1999; 66: 227-233. Jonga i-abstract.
  157. Li, H., Miyahara, T., Tezuka, Y., Namba, T., Suzuki, T., Dowaki, R., Watanabe, M., Nemoto, N., Tonami, S., Seto, H., kunye noT. kunye neKadota, S. Iziphumo zeefomula zekampo ekubuyiseleni amathambo kwi-vitro nakwi-vivo. II. Isifundo esineenkcukacha seBerberine. I-Biol Pharm Bull ngo-1999; 22: 391-396. Jonga i-abstract.
  158. Abe, F., Nagafuji, S., Yamauchi, T., Okabe, H., Maki, J., Higo, H., Akahane, H., Aguilar, A., Jimenez-Estrada, M., kunye noReyes- I-Chilpa, R. i-Trypanocidal constituents kwizityalo 1. Uvandlakanyo lwezityalo ezithile zaseMexico ngomsebenzi wazo we-trypanocidal kunye nezinto ezisebenzayo eGuaco, iingcambu ze-Aristolochia taliscana. I-Biol Pharm Bull 2002; 25: 1188-1191 (PubMed) (Umnqamlezo) Jonga i-abstract.
  159. IChatterjee P, uFranklin MR. I-cytochrome yabantu i-p450 inhibition kunye ne-metabolic-intermediate complex form of goldenseal extract kunye ne-methylenedioxyphenyl components. Ukuhanjiswa kweMetab yeziyobisi 2003; 31: 1391-7. Jonga i-abstract.
  160. Budzinski JW, Foster BC, Vandenhoek S, Arnason JT. Uvavanyo lwe-in vitro lwe-cytochrome yomntu P450 3A4 inhibition kukhetho olukhethiweyo lwezorhwebo kunye nemixube. Unyango lwe-2000; 7: 273-82. Jonga i-abstract.
  161. I-Huang XS, i-Yang GF, iPan YC. Iziphumo zeberberin hydrochloride kuxinzelelo lwegazi lwe-cyclosporine A kwizigulana ezifakwe kwintliziyo. UZhongguo Zhong Xi Yi Jie He Za Zhi 2008; 28: 702-4. Jonga i-abstract.
  162. UZhang Y, uLi X, uZou D, et al. Unyango lohlobo 2 lweswekile kunye nedyslipidemia kunye nesityalo sendalo i-alkaloid berberine. J Ikliniki ye-Endocrinol Metab 2008; 93: 2559-65. Jonga i-abstract.
  163. I-Cicero, i-AF, i-Rovati LC, kunye ne-Setnikar I. Iziphumo ze-Eulipidemic ze-berberine ezilawulwa zodwa okanye ngokudibeneyo nezinye iiarhente zokwehlisa i-cholesterol. Uphando lweklinikhi olungaboniyo. Iifayile. Ngo-2007; 57: 26-30. Jonga i-abstract.
  164. UVollekova A, uKost'alova D, uKettmann V, uToth J. Umsebenzi wokubola we-Mahonia aquifolium kunye ne-alkaloids zayo eziphambili. UPhytother Res 2003; 17: 834-7. Jonga i-abstract.
  165. UKim SH, uShin DS, u-O MN, et al. Ukuthintelwa kweprotein yomphezulu webhakteriya enamathela kwi-transpeptidase sortase yi-isoquinoline alkaloids. I-Biosci Biotechnol Biochem 2004; 68: 421-4 .. Jonga i-abstract.
  166. U-Li B, u-Shang JC, u-Zhou QX. [Uphononongo lwee-alkaloids zizonke ezivela kwi-rhizoma coptis chinensis kwizilonda zesisu esisilingelayo). I-Chin J Ukudibanisa i-2005; 11: 217-21. Jonga i-abstract.
  167. U-Ivanovska N, uPhilipov S. Funda malunga nesenzo sokuchasana ne-Berberis vulgaris yengcambu, amaqhekeza e-alkaloid kunye ne-alkaloids emsulwa. I-Int J Immunopharmacol 1996; 18: 553-61 (PubMed) (Umnqamlezo) Jonga i-abstract.
  168. UAng ES, uLee ST, uGan CS, et al. Ukuphonononga indima yolunye unyango kulawulo lokutsha kwenxeba: uvavanyo olungenamsebenzi ngokuthelekisa ioyile efumileyo yokutsha kunye neendlela eziqhelekileyo kulawulo lwezigulana ezinokutsha kwinqanaba lesibini. I-MedGenMed 2001; 3: 3. Jonga i-abstract.
  169. Tsai PL, Tsai TH. Ukukhupha i-hepatobiliary ye-berberine. Ukulahlwa kweMetab yeziyobisi 2004; 32: 405-12. . Jonga i-abstract.
  170. I-Wu X, i-Li Q, i-Xin H, i-Yu A, i-Zhong M. Iziphumo ze-berberine kuxinzelelo lwegazi lwe-cyclosporin A kulwamkelo lwentso olwamkelweyo: unyango lweklinikhi kunye ne-pharmacokinetic. I-Eur J Clin Pharmacol 2005; 61: 567-72. Jonga i-abstract.
  171. Khosla PG, Neeraj VI, Gupta SK, et al. I-Berberine, ichiza elinokubakho kwi-trachoma. UMfu Int Trach Pathol Ocul Trop Subtrop Sante Publique 1992; 69: 147-65. Jonga i-abstract.
  172. IHsiang CY, Wu SL, Cheng SE, Ho TY. I-Acetaldehyde-indased interleukin-1beta kunye ne-tumor necrosis factor-alpha yemveliso ithintelwe yi-berberine ngokusebenzisa inyukliya-kappaB ebonisa umendo kwiiseli zeHepG2. J Biomed Sci 2005; 12: 791-801. Jonga i-abstract.
  173. UAnis KV, uRajeshkumar NV, uKuttan R.Uthintelo lweekhemikhali ze-carcinogenesis yi-berberine kwiigundane kunye neempuku. UJ Pharm Pharmacol 2001; 53: 763-8. . Jonga i-abstract.
  174. UZeng XH, uZeng XJ, uLi YY. Ukusebenza kunye nokukhuseleka kwe-berberine yokusilela kwentliziyo yokuxinana kwesekondari ukuya kwi-ischemic okanye idiopathic dilated cardiomyopathy. NdinguJ Cardiol 2003; 92: 173-6. Jonga i-abstract.
  175. UJanbaz KH, uGilani AH. Izifundo malunga nezithintelo kunye nokunyanga kwe-berberine kwi-hepatotoxicity eyenziwe ngeekhemikhali kwiintonga. I-Fitoterapia 2000; 71: 25-33 .. Jonga i-abstract.
  176. UFukuda K, Hibiya Y, Mutoh M, et al. Ukuthintelwa yi-berberine ye-cyclooxygenase-2 yomsebenzi okhutshelweyo kwiiseli zomhlaza womntu. UJ Ethnopharmacol 1999; 66: 227-33. Jonga i-abstract.
  177. Ipaki KS, Kang KC, Kim JH, et al. Umahluko okhoyo kuthintelo lweeprotoberberines kwi-sterol kunye ne-chitin biosyntheses kwiCandida albicans. J Iintsholongwane zeChemother 1999; 43: 667-74. Jonga i-abstract.
  178. UKim JS, uTanaka H, ​​uShoyama Y.Uhlalutyo lwe-immunoquantitative ye-berberine kunye nezixhobo zayo ezinxulumene noko zisebenzisa i-monoclonal antibodies kumayeza e-herbal. Uhlalutyo 2004; 129: 87-91. Jonga i-abstract.
  179. I-Scazzocchio F, i-Corneta MF, i-Tomassini L, i-Palmery M. Umsebenzi we-Antibacterial we-Hydrastis canadensis kunye ne-alkaloids yayo eyodwa. IPlanta Med 2001; 67: 561-4. Jonga i-abstract.
  180. Ilanga D, iNkundla yeHS, iBeachey EH. I-Berberine sulphate ibhloka ukubambelela kwe-Streptococcus pyogenes kwiiseli ze-epithelial, i-fibronectin, kunye ne-hexadecane. Iiarhente zeAntimicrob Chemother 1988; 32: 1370-4. Jonga i-abstract.
  181. Amin AH, Subbaiah TV, Abbasi KM. I-Berberine sulfate: i-antimicrobial activity, i-bioassay, kunye nendlela yokusebenza. Ngaba uJ Microbiol 1969; 15: 1067-76. Jonga i-abstract.
  182. Bhide MB, Chavan SR, Dutta NK. Ukufunxa, ukuhanjiswa kunye nokukhutshwa kweberberine. Indiya J Med Res 1969; 57: 2128-31. Jonga i-abstract.
  183. U-Chan E.Ukususwa kwe-bilirubin kwi-albhamuin yi-berberine. I-Biol yeNeonate 1993; 63: 201-8. Jonga i-abstract.
  184. Ukusetyenziswa kwe-berberine kunyango lwe-giardiasis. NdinguJ Dis Umntwana 1975; 129: 866. Jonga i-abstract.
  185. I-Kaneda Y, Torii M, Tanaka T, Aikawa M. In vitro Iziphumo ze-berberine sulphate ekukhuleni nakwimeko ye-Entamoeba histolytica, Giardia lamblia kunye neTrichomonas vaginalis. UAnn Trop Med Parasitol 1991; 85: 417-25. Jonga i-abstract.
  186. Ilanga D, Abraham SN, Beachey EH. Impembelelo ye-berberine sulfate kwi-synthesis kunye nokubonakaliswa kwe-Pap fimbrial adhesin kwi-uropathogenic Escherichia coli. Iiarhente zeAntimicrob Chemother 1988; 32: 1274-7. Jonga i-abstract.
  187. URehman J, uDillow JM, uCarter SM, okqhubekayo. Ukonyuka kwemveliso ye-antigen-ekhethekileyo ye-antioglobulins G kunye no-M kulandela unyango lwe-vivo kunye nezityalo ezingamayeza i-Echinacea angustifolia kunye ne-Hydrastis canadensis. I-Immunol Lett 1999; 68: 391-5. Jonga i-abstract.
  188. Sheng WD, Jiddawi MS, Hong XQ, Abdulla SM. Unyango lwe-chloroquine-resistant malaria usebenzisa i-pyrimethamine ngokudibeneyo ne-berberine, tetracycline, okanye i-cotrimoxazole. EMpuma Afr Med J 1997; 74: 283-4. Jonga i-abstract.
  189. URabbani GH, uButler T, uKnight J, et al. Uvavanyo olulawulwa ngokungahleliwe lwonyango lwe-berberine sulphate yesifo sohudo ngenxa ye-enterotoxigenic Escherichia coli kunye neVibrio cholerae. J Ukuchaphazela iDis 1987; 155: 979-84. Jonga i-abstract.
  190. UTyler VE. IiHerbs zoKhetho. I-Binghamton, NY: Imveliso yezeMveliso yezeMveliso, ngo-1994.
  191. Blumenthal M, ed. IKhomishini epheleleyo yaseJamani i-E Monographs: Isikhokelo sonyango kumaYeza eHerbal. Dlulisa. S. Klein. IBoston, MA: IBhunga laseMelika leBhotani, i-1998.
  192. Monographs ekusebenziseni amayeza iziyobisi zezityalo. I-Exeter, e-UK: I-European Scientific Co-op Phytother, ngo-1997.
Ukuhlaziywa okokugqibela-01/26/2021

Kucetyiswa

Iiseli zeziqu: ziyintoni, ziindidi kwaye kutheni uzigcina
Zempilo

Iiseli zeziqu: ziyintoni, ziindidi kwaye kutheni uzigcina

Ii eli ze tem zii eli ezingakhange zahluleke ukwahlulahlula ii eli kwaye zinamandla okuzihlaziya kwaye ziveli e iintlobo ezahlukeneyo zee eli, zikhokelela kwii eli ezizodwa ezinoxanduva lokwenza izicw...
Iindlela ezili-8 zokuyeka ukurhona ngokukhawuleza
Zempilo

Iindlela ezili-8 zokuyeka ukurhona ngokukhawuleza

Iindlela ezimbini ezilula zokuyeka ukurhona kukuhlala ulala ngecala lakho okanye e i wini akho kwaye u ebenzi e iipateni ezicha ayo ezimpumlweni zakho, kuba zilungi elela ukuphefumla, ukunciphi a ukwe...